SERA
Sera Prognostics, Inc.
Medical Devices · Healthcare · United States
2.04
close · 2026-10-30
value
6
cheaper than peers6
quality
92
stronger fundamentals92
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.35× | 76 |
| earnings yield, latest year | -32.8% | 24 |
| earnings yield, 1 year ago | -48.5% | 23 |
| cash flow yield, 1 year ago | -19.0% | 22 |
| earnings yield, 2 years ago | -56.9% | 21 |
| cash flow yield, latest year | -32.7% | 17 |
| earnings yield, 3 years ago | -70.1% | 17 |
| cash flow yield, 2 years ago | -33.9% | 14 |
| cash flow yield, 3 years ago | -44.0% | 14 |
| price to sales | 1149.67× | 1 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 76.5% | 98 |
| debt to equity | 5.1% | 89 |
| return on equity | -45.0% | 35 |
3 of 4 measures available
Facts
| market cap | $80M |
| free cash flow | -$18.9M |
| employees | 71 |
| first trade | 2021-07-15 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-31 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.67 | -0.99 | -1.16 | -1.43 |
| free cash flow | -$26.3M | -$15.3M | -$27.3M | -$35.4M |
| net income | -$31.9M | -$32.9M | -$36.2M | -$44.2M |
| revenue | $81,000 | $77,000 | $306,000 | $268,000 |
| unusual items | $332,000 | $1.0M | $2.0M | $1.1M |